Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | PLG | P00747 | 1/20 | 0.31 |
| ▸ | PLAT | P00750 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13616453 | 0.94 | LMNA (0.34) | LMNAKDM4EGMNNPMP22TFPI2 | |
| SCHEMBL18651825 | 0.88 | KDM4E (0.31) | LMNAKDM4EGMNNPMP22TFPI2 | |
| SCHEMBL13630600 | 0.82 | DPP4 (0.31) | — | |
| SCHEMBL12707402 | 0.82 | TP53 (0.35) | LMNAKDM4EGMNNPMP22TFPI2 | |
| SCHEMBL18651826 | 0.81 | — | — | |
| SCHEMBL4663418 | 0.80 | TFPI2 (0.38) | LMNAKDM4EGMNNPMP22TFPI2 | |
| SCHEMBL754254 | 0.79 | ALDH1A1 (0.43) | LMNAKDM4EGMNNPMP22TFPI2 | |
| SCHEMBL14004139 | 0.79 | PPM1B (0.37) | LMNAKDM4EGMNNPMP22TFPI2 | |
| SCHEMBL11056909 | 0.77 | TFPI2 (0.35) | LMNAKDM4EGMNNPMP22TFPI2 | |
| SCHEMBL15069506 | 0.76 | TFPI2 (0.39) | LMNAKDM4EGMNNPMP22TFPI2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9850223-B2 | Metal catalysts for selective formation of cyclic carbonates, process for preparing cyclic carbonate using the same and use of cyclic carbonate | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-12-26 | — | — | US | disclosed |
| US-9850223-B2 | Metal catalysts for selective formation of cyclic carbonates, process for preparing cyclic carbonate using the same and use of cyclic carbonate | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-12-26 | — | — | US | disclosed |
| US-20170081302-A1 | METAL CATALYSTS FOR SELECTIVE FORMATION OF CYCLIC CARBONATES, PROCESS FOR PREPARING CYCLIC CARBONATE USING THE SAME AND USE OF CYCLIC CARBONATE | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-03-23 | — | — | US | disclosed |
| US-20170081302-A1 | METAL CATALYSTS FOR SELECTIVE FORMATION OF CYCLIC CARBONATES, PROCESS FOR PREPARING CYCLIC CARBONATE USING THE SAME AND USE OF CYCLIC CARBONATE | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2017-03-23 | — | — | US | disclosed |
| US-20070059478-A1 | Optical recording medium and production method thereof; and optical recording apparatus and optical reproducing apparatus | FUJI PHOTO FILM CO., LTD. | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170081302-A1 | METAL CATALYSTS FOR SELECTIVE FORMATION OF CYCLIC CARBONATES, PROCESS FOR PREPARING CYCLIC CARBONATE USING THE SAME AND USE OF CYCLIC CARBONATE | CA2, TMCO1, CA1 | LMNA 2652/4885KDM4E 1427/4885GMNN 2407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.